Search results
Results from the WOW.Com Content Network
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Drug Fair (company liquidated in 2009, assets purchased by Walgreens) Eckerd (acquired by Rite Aid in 2007) Fay's Drug (purchased by JC Penney and rebranded as Eckerd in 1997) Farmacias El Amal; Fred's (company liquidated in 2019) GO Guy (purchased by Pay'n'Save in 1987) Genovese Drug Stores (acquired by Eckerd parent JC Penney in 1998 ...
Pages in category "Pharmaceutical companies of the United States" The following 200 pages are in this category, out of approximately 215 total. This list may not reflect recent changes .
For premium support please call: 800-290-4726 more ways to reach us
As of 2019, twelve of top 20 biopharmaceutical companies in the world has U.S. headquarters in the state. [ 9 ] [ 10 ] Below is a list of notable New York metropolitan area biotechnology and pharmaceutical corporations , including companies with either global or U.S. headquarters in the metropolitan region encompassing and surrounding New York ...
This page was last edited on 14 December 2024, at 09:47 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The company's business is divided into two business sectors: Innovative Medicine and MedTech. Johnson & Johnson Innovation, LLC (JJI) is a subsidiary of Johnson & Johnson. [ 111 ] JJI focuses on early-stage, life science , and technology innovations to advance the company's research and development pipeline. [ 112 ]